Recon: Pfizer raises profit forecast on cancer, heart drug sales amid declining COVID revenue; Sanofi sues Sarepta over gene therapy patents
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States